Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis
- PMID: 32109638
- DOI: 10.1016/j.cgh.2020.02.038
Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis
Comment in
-
Reply.Clin Gastroenterol Hepatol. 2020 Dec;18(13):3057-3058. doi: 10.1016/j.cgh.2020.03.023. Clin Gastroenterol Hepatol. 2020. PMID: 33190745 No abstract available.
Comment on
-
Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis.Clin Gastroenterol Hepatol. 2020 Oct;18(11):2526-2534.e9. doi: 10.1016/j.cgh.2019.12.032. Epub 2020 Jan 8. Clin Gastroenterol Hepatol. 2020. PMID: 31926340 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical